Trademark applications and grants for Myokardia Inc. Myokardia Inc has 27 trademark applications. The latest application filed is for "CAMZYOS"
Patent Application | Date |
---|---|
POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUORO- ETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE 20220289709 - 17/678569 Zhong; Min ;   et al. | 2022-09-15 |
TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUORO- ETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE 20220265629 - 17/612468 Tamby; Jean-Francois ;   et al. | 2022-08-25 |
TREATMENT OF HCM WITH PYRIMIDINEDIONE COMPOUNDS 20220226324 - 17/701863 Semigran; Marc J. ;   et al. | 2022-07-21 |
4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS 20220117955 - 17/407545 Oslob; Johan ;   et al. | 2022-04-21 |
SUBSTITUTED 5,6,7,8-TETRAHYDROPYRIDO[2,3-D]PYRIMIDINE-2,4-DIONES FOR TREATING CARDIAC DISEASES 20220106314 - 17/554353 Grillo; Mark ;   et al. | 2022-04-07 |
CAGE Code | 8B0J8 | MYOKARDIA, INC. 3300866638 |
S.A.M. Registration | 8B0J8 [78698088] | MYOKARDIA, INC. |
SEC | 0001552451 | MyoKardia Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.